Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Elaine H. is listed as CEO | Founder | Passionate Scientist-turned Inventor-turned-Entrepreneur | Helping new science become transformative therapeutics | Moderator | Keynote Speaker | Advocate at Cadenza Bio, based in Oklahoma City, Oklahoma, United States. AeroLeads shows a matched LinkedIn profile for Elaine H..
Elaine H. previously worked as COO, Founder at Cadenza Bio and Executive In Residence at Tulane University School Of Medicine. Elaine H. holds Postgraduate Degree, Nosocomial Infections from University Of Oklahoma Health Sciences Center.
This section adds company-level context without repeating Elaine H.'s masked contact details.
Review company-level records connected to Elaine H. before choosing the right outreach path.
I am an accomplished pharmaceutical executive with a demonstrated history of success in key areas such as drug research and development, venture capital, strategy development, and company building. With hands-on experience in driving innovation and delivering life-changing therapies, I bring valuable insights into critical milestones and regulatory requirements for emerging technologies and companies.My expertise in venture capital has enabled me to forge strong connections with investors, entrepreneurs, and industry leaders. Through this extensive network, I have played a pivotal role in securing funding for promising early-stage companies and facilitating technology transfer to drive growth and integration in the biotech landscape.In addition, I have excelled in company building, leveraging my understanding of organizational dynamics to assemble high-performing teams and cultivate a strong company culture. By optimizing operational efficiency and attracting top-tier talent, I have contributed to sustained success and competitive advantage.With a strategic mindset and a deep understanding of the pharmaceutical landscape, I have developed and implemented data-driven strategies that optimize resource allocation, capitalize on market trends, and foster long-term growth. If you're an investor, company, or executive seeking fresh opportunities, let's connect. Together, we can navigate the dynamic healthcare landscape, capitalize on emerging prospects, and propel success in the industry.
Listed skills include Biotechnology, Molecular Biology, Biochemistry, Commercialization, and 26 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
• Building and implementing strategy focused on development of novel therapeutic drugs for treatment of demyelinating, inflammatory and neurodegenerative diseases based on the research of the Drs. Katzenellenbogen and Tiwari-Woodruff• Leading start-up launch and fundraising effort
CLAIRIgene is a preclinical stage biopharmaceutical company focused on development gene therapies for neurodegenerative diseases. Powered by an all-in-one vector technology, our platform offers the unprecedented opportunity to modify epigenetic markers to control the expression of disease-associated genes in neurodegenerative diseases such as Alzheimer’s Disease and Parkinson’s Disease.
Ascend BioVentures was formed to help commercialize early-stage therapeutics. Our goal is to shepherd promising drug candidates through the riskiest, early stages of development. We do this by identifying innovative and transformative therapeutics and efficiently launching and funding companies focused on preclinical drug development. We evaluate technologies and are location and indication agnostic. We require known mechanism of action and/or in vivo efficacy data. Please contact us if you are interested in investing or partnering with us. We are also always recruiting experienced executives and consultants for our companies. Our portfolio companies benefit from experienced management, scientists, consultants and investors from all over the world. The Ascend portfolio today consists of several companies in preclinical and clinical development.
Oklahoma City, Oklahoma, Us
Otologic Pharmaceutics is a clinical-stage company developing new and innovative treatments to address the global problem of hearing-loss and hearing-related diseases. Otologic Pharmaceutics subsidiaries include:Auditus: a clinical stage asset designed to reduce acute acoustic trauma including choclear implant-related hearing loss and tinnitusAutigen: a preclinical program focused on regrowing the sensory hairs cells within the cochlear. The is a joint collaboration with Boehringer Ingelheim
The Study is a wine pub located in the historic Film Row district in downtown OKC. We offer over 64 wines by the glass and host virtual wine classes and tastings. We also offer a local wine club where, every month you get introduced to new wines along with local pairing suggestions.
Founded in early 2019, Kirrhos Pharmaceuticals is advancing a novel, “first-in-class”therapeutic to treat a progressive non-alcoholic fatty liver disease known as NASH. Builtupon a platform technology licensed from a California-based research company, Kirrhosanticipates future development of treatments for other fibrotic disease indications suchpulmonary fibrosis, kidney fibrosis and potentially cancer.
Managed the research and operations of a portfolio of startup biotechnology companies alongside an experienced team at Accele BioPharma and Accele Venture Partners, a biotechnology accelerator and venture fund that identifies, funds, and manages early-stage life science companies. The Accele Biopharma portfolio today consists of four companies in preclinical and clinical development:- Synereca Pharmaceuticals: Focused on developing inhaled antibiotic potentiator product for the treatment of multi-drug resistant Gram-negative lung infections with a specific focus on ESKAPE pathogens and cystic fibrosis. - Otologic Pharmaceutics: Clinical and preclinical stage products for the treatment of hearing loss, tinnitus, and Meniere's Disease.-Pamlico BioPharma: Platform for isolation of fully-human monoclonal antibodies for infectious disease including pneumonia, rabies, & cancer diagnostics and therapeutics- Jortan Pharmaceuticals: Diabetes therapeutic and Vivarium
Oklahoma City, Ok, Us
Served as a Venture Advisor -Provided capital to early and late stage startups. Closed over $7.6 M in equity investment deals. -Facilitated access to other Angel and Venture Capital markets. -Advised startups on their overall business commercialization efforts including assisting with market assessments, development of business strategies, evaluation of Business Plans, competitor analysis, preparation of investor presentations. Director, Proof of Concept Center-Created and managed the regional Proof-of-Concept Center, a 10 week accelerator program which began as a collaboration between i2E, the Oklahoma Center for the Advancement of Science and Technology, and Oklahoma universities. -The Proof-of-Concept Center was originally designed to nurture the development of high priority, early-stage university technologies and accelerate their commercialization. Expanded to include private research institutes, and startups. The Proof-of Concept Center assists universities with technology validation, customer evaluation, market-based prototype development, and targeted commercialization efforts to create a foundation for viable startups.-Program expanded to include startups and non university technologies.Director, Venture Assessment Program-Created and managed the Venture Assessment Program, a 3 week mini accelerator that helps startups investigate the product-market fit and business opportunity of their early stage concepts.
Norman, Oklahoma, Us
Oversaw OU's intellectual property management, economic development, and technology-based entrepreneurial activities for the Norman and Tulsa campuses. Managed a diverse IP portfolio including but not limited to: oil and gas, weather, biotech, medical, alternative energy, and telecommunications engineering. Was responsible for the technical evaluation as well as marketing, licensing, and commercialization of patents, copyrights, and other intellectual property developed at OU.
South San Francisco, Ca, Us
Senior Protein Chemist. Engaged in research efforts related to Alzheimer's disease.
Oklahoma City, Ok, Us
Did extensive research on nosocomial infections, specifically Clostridium difficile-associated disease. Investigated the systemic events induced by C. difficile, which were previously unknown.Broad experience in biochemistry and microbiology. Specifically experienced in protein purification and analysis including, but not limited to: process development, scale-up procedures, batch production/enzyme preparation records, and protein detection/analysis. Also skilled in a variety of animal models. Strong background in molecular biology, microbial genetics, cell biology, and zoology.
Norman, Oklahoma, Us
Developed the zebrafish embryo as a model for elucidating the systemic effects of bacterial toxins, specifically Anthrax toxin and Large Clostridial toxins. Studied the teratogenic impact of lethal toxin from Bacillus anthracis. Discovered the cardiotoxicity of toxin B from Clostridium difficile. Investigated the previously unknown cytotoxic effects of edema toxin from B. anthracis. Taught the following upper division courses: microbial physiology and molecular biology, and pathogenic microbiology and ecology
Worked in the violent crime unit, biology department. Also worked part time in the crime scene photography lab.
Quick answers generated from the profile data available on this page.
Elaine H. works for Cadenza Bio.
Elaine H. is listed as CEO | Founder | Passionate Scientist-turned Inventor-turned-Entrepreneur | Helping new science become transformative therapeutics | Moderator | Keynote Speaker | Advocate at Cadenza Bio.
Elaine H. is based in Oklahoma City, Oklahoma, United States while working with Cadenza Bio.
Elaine H. has worked for Cadenza Bio, Tulane University School Of Medicine, Clairigene, Ascend Bioventures, and Otologic Pharmaceutics.
You can use AeroLeads to view verified contact signals for Elaine H. at Cadenza Bio, including work email, phone, and LinkedIn data when available.
Elaine H. holds Postgraduate Degree, Nosocomial Infections from University Of Oklahoma Health Sciences Center.
Elaine H. is listed with skills including Biotechnology, Molecular Biology, Biochemistry, Commercialization, Life Sciences, Microbiology, Entrepreneurship, and Protein Chemistry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts